HLS Stock Overview
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 3/6 |
Past Performance | 0/6 |
Financial Health | 3/6 |
Dividends | 0/6 |
Healius Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$1.33 |
52 Week High | AU$3.31 |
52 Week Low | AU$1.09 |
Beta | 0.65 |
1 Month Change | 4.74% |
3 Month Change | -18.96% |
1 Year Change | -57.67% |
3 Year Change | -67.52% |
5 Year Change | -53.67% |
Change since IPO | -5.36% |
Recent News & Updates
Recent updates
Is Healius Limited (ASX:HLS) Trading At A 50% Discount?
Mar 15At AU$3.07, Is It Time To Put Healius Limited (ASX:HLS) On Your Watch List?
Feb 06Here's Why Healius (ASX:HLS) Can Manage Its Debt Responsibly
Dec 02Is Now An Opportune Moment To Examine Healius Limited (ASX:HLS)?
Oct 13Are Investors Undervaluing Healius Limited (ASX:HLS) By 48%?
Aug 02Why Healius Limited (ASX:HLS) Could Be Worth Watching
May 23Healius Limited's (ASX:HLS) Prospects Need A Boost To Lift Shares
Apr 02Healius (ASX:HLS) Is Paying Out A Larger Dividend Than Last Year
Feb 25Shareholder Returns
HLS | AU Healthcare | AU Market | |
---|---|---|---|
7D | 6.4% | 5.3% | 1.5% |
1Y | -57.7% | -13.6% | 11.6% |
Return vs Industry: HLS underperformed the Australian Healthcare industry which returned -13.6% over the past year.
Return vs Market: HLS underperformed the Australian Market which returned 11.6% over the past year.
Price Volatility
HLS volatility | |
---|---|
HLS Average Weekly Movement | 8.2% |
Healthcare Industry Average Movement | 6.8% |
Market Average Movement | 8.7% |
10% most volatile stocks in AU Market | 17.1% |
10% least volatile stocks in AU Market | 3.2% |
Stable Share Price: HLS's share price has been volatile over the past 3 months.
Volatility Over Time: HLS's weekly volatility (8%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
1994 | 10,500 | Paul Anderson | https://www.healius.com.au |
Healius Limited provides specialty diagnostic services to consumer and practitioners in Australia. The company operates through three segments: Pathology, Imaging, and Others. It offers diagnostic imaging services, private medical laboratory, and pathology services.
Healius Limited Fundamentals Summary
HLS fundamental statistics | |
---|---|
Market cap | AU$929.41m |
Earnings (TTM) | -AU$984.10m |
Revenue (TTM) | AU$1.69b |
0.6x
P/S Ratio-1.0x
P/E RatioIs HLS overvalued?
See Fair Value and valuation analysisEarnings & Revenue
HLS income statement (TTM) | |
---|---|
Revenue | AU$1.69b |
Cost of Revenue | AU$1.16b |
Gross Profit | AU$532.00m |
Other Expenses | AU$1.52b |
Earnings | -AU$984.10m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -1.36 |
Gross Margin | 31.45% |
Net Profit Margin | -58.17% |
Debt/Equity Ratio | 39.3% |
How did HLS perform over the long term?
See historical performance and comparison